Revance Therapeutics shares owned by Palo Alto Investors
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Palo Alto Investors
from 13F filings
Historical chart of Palo Alto Investors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Palo Alto Investors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $8.4M | 1.6M | 5.19 |
| 2024-06-30 | $14M | 5.3M | 2.57 |
| 2024-03-31 | $26M | 5.2M | 4.92 |
| 2023-12-31 | $46M | 5.2M | 8.79 |
| 2023-09-30 | $60M | 5.2M | 11.47 |
| 2023-06-30 | $132M | 5.2M | 25.31 |
| 2023-03-31 | $170M | 5.3M | 32.21 |
| 2022-12-31 | $98M | 5.3M | 18.46 |
| 2022-09-30 | $119M | 4.4M | 27.00 |
| 2022-06-30 | $61M | 4.4M | 13.82 |
| 2022-03-31 | $86M | 4.4M | 19.50 |
| 2021-12-31 | $71M | 4.4M | 16.32 |
| 2021-09-30 | $89M | 3.2M | 27.86 |
| 2021-06-30 | $95M | 3.2M | 29.64 |
| 2021-03-31 | $90M | 3.2M | 27.95 |
| 2020-12-31 | $76M | 2.7M | 28.34 |
| 2020-09-30 | $50M | 2.0M | 25.14 |
| 2020-06-30 | $42M | 1.7M | 24.42 |
| 2020-03-31 | $9.1M | 616k | 14.80 |
| 2019-12-31 | $1.4M | 89k | 16.23 |
| 2014-09-30 | $1.6M | 80k | 19.34 |
| 2014-06-30 | $3.1M | 92k | 34.00 |
| 2014-03-31 | $2.9M | 92k | 31.50 |